These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 11185637)

  • 1. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the safety and efficacy of telmisartan and enalapril, with the potential addition of frusemide, in moderate-renal failure patients with mild-to-moderate hypertension.
    Hannedouche T; Chanard J; Baumelou B;
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):246-54. PubMed ID: 11881131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB; Reilly PA
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40mg and hydrochlorothiazide 12.5mg in adult Indian patients with mild to moderate hypertension.
    Jayaram S; Lahoti S; Chandrasekharan S; Ganesan R; Muralidharan RS; Mishra AB; Sodhi SS; Rajadhyaksha GC; Jain SD; Kadam GS; Gawde A; Desai A
    J Indian Med Assoc; 2004 Sep; 102(9):525-7. PubMed ID: 15887845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension.
    McGill JB; Reilly PA
    Clin Cardiol; 2001 Jan; 24(1):66-72. PubMed ID: 11195609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and tolerability of telmisartan 40 mg vs. enalapril 10 mg in the treatment of mild-to-moderate hypertension: a multicentre, double-blind study in Taiwanese patients.
    Chen JH; Cheng JJ; Chen CY; Chiou HC; Huang TY; Tsai CD; Fu MM; Cherng WJ
    Int J Clin Pract Suppl; 2004 Dec; (145):29-34. PubMed ID: 15617456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension.
    Nalbantgil I; Nalbantgil S; Ozerkan F; Yilmaz H; Gürgün C; Zoghi M; Aytimur M; Onder R
    Int J Clin Pract Suppl; 2004 Dec; (145):50-4. PubMed ID: 15617460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
    Manolis AJ; Reid JL; de Zeeuw D; Murphy MB; Seewaldt-Becker E; Köster J;
    J Hypertens; 2004 May; 22(5):1033-7. PubMed ID: 15097245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.
    Zhu DL; Bays H; Gao P; Mattheus M; Voelker B; Ruilope LM
    Clin Ther; 2012 Jul; 34(7):1613-24. PubMed ID: 22717420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Littlejohn T; Mroczek W; Marbury T; VanderMaelen CP; Dubiel RF
    Can J Cardiol; 2000 Sep; 16(9):1123-32. PubMed ID: 11021956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension.
    Neutel JM; Smith DH; Reilly PA
    Int J Clin Pract; 1999; 53(3):175-8. PubMed ID: 10665127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
    Karlberg BE; Lins LE; Hermansson K
    J Hypertens; 1999 Feb; 17(2):293-302. PubMed ID: 10067800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study.
    Neldam S; Edwards C; Jones R;
    Curr Med Res Opin; 2011 Nov; 27(11):2145-53. PubMed ID: 21955225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
    Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L
    Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adjunctive effect of telmisartan in patients with hypertension uncontrolled on current antihypertensive therapy.
    Gil-Extremera B; Ma PT; Yulde J; Kalnins U; Harkin N; Williams L
    Int J Clin Pract; 2003 Dec; 57(10):861-6. PubMed ID: 14712886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.